➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
AstraZeneca
McKinsey
Boehringer Ingelheim
Baxter

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. (D. Del. 2019)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-10-17 1 Complaint expiration of U.S. Patents Nos. 8,101,659 (the “’659 patent”), 8,796,331 (the “’331 patent”), 8,877,938 (… (the “’938 patent”), and/or 9,388,134 (the “’134 patent”). … THE PATENTS-IN-SUIT AND ENTRESTO® 178. Novartis is the owner of the ’659 patent, titled…copy of the ’659 patent is attached hereto as Exhibit A. 179. The ’659 patent claims, inter alia…the ’331 patent, titled “Methods of treatment and pharmaceutical composition.” The ’331 patent was duly External link to document
2019-10-17 3 ANDA Form Date 8,101,659 January 14, 2023 8,796,331 …received) Date of Expiration of Patents: U.S. Patent No. Expiration Date… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: See Attached. Date of Expiration of Patent: See Attached. Stay Deadline: See Attached. (myr… ) SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG External link to document
2019-10-17 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659 ;8,796,331 ;8,877,938… 17 October 2019 1:19-cv-01979 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-02-05 59 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,468,390 B2 ;US 8,404,744 … 17 October 2019 1:19-cv-01979 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Moodys
Dow
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.